Clinical Trial: A Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails

U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07382427) titled 'A Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails' on Nov. 20, 2025.

Brief Summary: Onychomycosis is a fungal infection of the toenail caused by a range of organisms, including dermophytes, non-dermophyte molds, and yeasts. Topical antifungals are often used for mild to moderate onychomycosis, especially when oral therapy is contraindicated. Generally, topical antifungal agents are well-tolerated with minimal side effects, but they are less effective than oral antifungal therapies due to poor nail penetration. Consequently, the c...